1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

22 Jan 2020
Admin
News Article

Zydus Inks Licensing Agreement With Cms To Develop & Commercialise Desidustat In Greater China

Zydus, A Leading Discovery Based Global Pharmaceutical Company, Has Entered Into A Licensing Agreement With China Medical System Holdings Limited (Cms) For The Development And Commercialisation Of Desidustat, A Novel Oral Hif-Ph Inhibitor For The Treatment Of Anaemia In Patients With Chronic Kidney Disease (Ckd) Not-On-Dialysis And For The Treatment Of Anaemia Ckd Patients On Dialysis In Greater China.It Has Been Reported That More Than 120 Million People Are Estimated To Be Living With Ckd In China. Ckd Is A Serious Medical Condition Which Is An Unmet Healthcare Need Involving Gradual Loss Of Functioning Of Kidneys Eventually Leading To Kidney Failure. If Kidneys Are Healthy They Will Naturally Secrete Beneficial Levels Of A Hormone Called Erythropoietin (Epo), Which Encourages Red Blood Cell Production That Carry Oxygen To The Muscles And Brain. If The Kidneys Are Impaired They Will Produce Reduced Levels Or Tire Of Epo Production Completely, Leading To Fatigue And Anaemia.Anaemia Is One Of The Frequent Complications Of Ckd. A Survey In China Showed That The Prevalence Of Anaemia In Patients At Ckd Stage 1 To 5 Were 22.0%, 37.0%, 45.4%, 85.1%, And 98.2%, Respectively. The Target-Achieving Rate Was Only 8.2% For Anaemia Patients In Non-Dialysis Ckd And 35.2% For Dialysis Ckd, Showing Unmet Healthcare Need.Speaking On The Development, Pankaj R. Patel, Chairman, Zydus Group Said, â

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!